Jiangsu Nhwa Pharmaceutical Co., LTD (SHE:002262)
China · Delayed Price · Currency is CNY 22.77
-0.86 (-3.64%)
At close: Feb 2, 2026
SHE:002262 Revenue
Jiangsu Nhwa Pharmaceutical Co., LTD had revenue of 1.46B CNY in the quarter ending September 30, 2025, with 5.70% growth. This brings the company's revenue in the last twelve months to 6.02B, up 8.90% year-over-year. In the year 2024, Jiangsu Nhwa Pharmaceutical Co., LTD had annual revenue of 5.70B with 13.01% growth.
Revenue (ttm)
6.02B
Revenue Growth
+8.90%
P/S Ratio
3.84
Revenue / Employee
1.02M
Employees
5,923
Market Cap
23.13B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.70B | 656.13M | 13.01% |
| Dec 31, 2023 | 5.04B | 742.99M | 17.28% |
| Jan 1, 2023 | 4.30B | 362.85M | 9.22% |
| Jan 1, 2022 | 3.94B | 574.36M | 17.09% |
| Dec 31, 2020 | 3.36B | -788.01M | -18.99% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Joincare Pharmaceutical Group Industry | 15.20B |
| Livzon Pharmaceutical Group | 11.85B |
| Apeloa Pharmaceutical Co.,Ltd | 10.50B |
| Zhejiang Huahai Pharmaceutical | 8.71B |
| Tasly Pharmaceutical Group | 8.35B |
| Hubei Jumpcan Pharmaceutical | 6.14B |
| Kangmei Pharmaceutical | 5.28B |
| Chengdu Kanghong Pharmaceutical Group | 4.67B |
Jiangsu Nhwa Pharmaceutical Co., LTD News
- 5 weeks ago - Luye Pharma Grants Nhwa Rights To Commercialize Three LAI Antipsychotics In Chinese Mainland - Nasdaq